FCRL5 and neoplasm: We found that infusion with FcRH5 CAR-T or BCMA CAR-T cells from two different donors eliminated tumor lumps throughout the body, as shown by bioluminescence imaging (Fig. 4b, c), which effectively translated to prolonged mouse survival time (Fig. 4d).